Oruka Therapeutics(GB:0H79)
GB:0H79
Oruka Therapeutics ownership
Oruka Therapeutics (0H79) Ownership - Who Owns Oruka Therapeutics?
0 Followers
Oruka Therapeutics (0H79) Ownership Overview
- 7.49% Insiders
- 29.00% Mutual Funds
- 20.58% Other Institutional Investors
- 14.95% ETFs
- 27.98% Public Companies and Individual Investors
The ownership structure of Oruka Therapeutics (GB:0H79) stock is a mix of institutional, retail, and individual investors. Approximately 64.54% of the company’s stock is owned by Institutional Investors, 7.49% is owned by Insiders, and 27.98% is owned by Public Companies and Individual Investors.
Institutional holdings as of (latest 13F reporting period).
The ownership structure of Oruka Therapeutics (GB:0H79) stock is a mix of institutional, retail, and individual investors. Approximately 64.54% of the company’s stock is owned by Institutional Investors, 7.49% is owned by Insiders, and 27.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 14, 2026 | Laura Lee Sandler | $86,713 | |
| Sep 14, 2026 | Paul T. Quinlan | $99,443 | |
| Sep 14, 2026 | Lawrence Otto Klein | $234,681 | |
| Jun 30, 2026 | Fairmount Funds Management Llc | $300,014,406 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | $17,414,701 | |
| Dec 31, 2025 | Blackstone Inc. | $35,323,516 | |
| Dec 31, 2025 | Perceptive Advisors Llc | $44,752,745 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 5,210,214 | Institution | 7.68% | ― |
| Vanguard | 3,762,363 | Institution | 5.55% | ― |
| Fairmount Funds Management Llc | 3,705,262 | Insider | 5.46% | ― |
| Peter Harwin | 3,705,262 | Institution | 5.46% | ― |
| Ishares | 2,548,610 | Institution | 3.76% | ― |
| Vanguard Index Funds | 2,305,645 | Institution | 3.40% | ― |
| Fidelity Mt. Vernon Street Trust | 2,015,491 | Institution | 2.97% | ― |
| Spdr | 1,869,063 | Institution | 2.76% | ― |
| Peter Kolchinsky | 1,554,597 | Institution | 2.29% | ― |
| Smallcap World Fund Inc | 1,527,592 | Institution | 2.25% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,305,645 | Institution | 3.40% | ― |
| Fidelity Mt. Vernon Street Trust | 2,015,491 | Institution | 2.97% | ― |
| Smallcap World Fund Inc | 1,527,592 | Institution | 2.25% | ― |
| Fidelity Securities Fund | 1,462,630 | Institution | 2.16% | ― |
| Fidelity Select Portfolios | 1,442,683 | Institution | 2.13% | ― |
| New Economy Fund | 1,323,308 | Institution | 1.95% | ― |
| Fidelity Advisor Series Vii | 1,165,386 | Institution | 1.72% | ― |
| Fidelity Salem Street Trust | 725,381 | Institution | 1.07% | ― |
| Fidelity Concord Street Trust | 513,840 | Institution | 0.76% | ― |
| Franklin Strategic Series | 504,275 | Institution | 0.74% | ― |
FAQ
Who Owns Oruka Therapeutics (GB:0H79)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 64.54% of the company's stock is held by institutional investors, 7.49% is held by insiders, and 27.98% is held by public companies and individual investors.
What percentage of Oruka Therapeutics (GB:0H79) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 64.54% of Oruka Therapeutics (GB:0H79) stock is held by institutional investors: 29.00% by mutual funds, 14.95% by ETFs and 20.58% by other institutional investors.
What percentage of Oruka Therapeutics (GB:0H79) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 27.98% of Oruka Therapeutics (GB:0H79) stock is held by public companies and individual investors.
Who owns the most shares of Oruka Therapeutics (GB:0H79)?
BlackRock, Inc. owns the most shares of Oruka Therapeutics (GB:0H79).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

